Por: The Times-Tribune Opinion November 23, 2023
Editor: If you are afraid of the COVID vaccines for some reason, I understand that. Fear is a devilish thing. You are forgiven.... + full article
Time USA Nation May 18, 2023
In a released by Pew Research Center, the percentage of who said parents should be able to forego the MMR (measles, mumps, and rubella) vaccine for their public school children, even if it may create a health risk for others, more than doubled from 20% in 2019 to 42% in 2023.... + más
What Are the Duties of A Trustee? | Forbes
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
The Boston Globe USA Nation April 28, 2023
Anti-vaccine advocates have for years used foreboding imagery of syringes to paint immunizations as dark and dangerous. But recent vaccine conspiracy theories are casting an air of fear around more mundane things — like cows and lettuce.In widespread posts online in recent... + más
Shaikin: Baseball embracing the 'flukes' and plenty of added revenue this postseason | Los Angeles Times
ABC News USA Tech April 26, 2023
ABC News USA Health April 25, 2023
Associated Press USA Science April 25, 2023
Los Angeles Times USA Science April 25, 2023
Anti-vaccine advocates have for years used foreboding imagery of syringes to paint immunizations as dark and dangerous. But recent vaccine conspiracy theories are casting an air of fear around more mundane things — like cows and lettuce. In widespread posts online in recent... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Amid conspiracy theories circulating online, experts confirm COVID vaccines are not in the food supply | The Boston Globe
Politico USA Health October 15, 2022
Biden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
About iurex | Privacy Policy | Disclaimer |